Other languages Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Real-time Estimate Tradegate Other stock markets 15:14:01 18/06/2024 BST			5-day change	1st Jan Change
9.088 ^EUR	+3.04%		+2.91%	-7.30%

04:54am	Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients	MT
05-23	Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients	03:54am
Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America	05-23
Clinuvel Pharmaceuticals Launches Share Buyback Program	03-14
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.	03-13
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.	03-13
Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga	03-07
Clinuvel Reports Positive Results in SCENESSE Study	03-04
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-21
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment	18/10/23
Clinuvel Pharmaceuticals Limited Announces Board Changes	29/09/23
Clinuvel Pharmaceuticals Teams Up With Vitiligo Experts to Assess Scenesse	13/09/23
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023	29/08/23
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/08/23
Clinuvel Pharmaceuticals Secures Supply Contract for Porphyria Medication with the US Department of Veterans Affairs	26/07/23
Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders	14/07/23
Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial	20/03/23
Clinuvel Pharmaceuticals Limited Announces Technical Note - CUV803 Study and AIS	20/03/23
Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with PRENUMBRA Instant	19/03/23
Clinuvel Pharmaceuticals Limited Present DNA Repair Data At American Academy of Dermatology Meeting	16/03/23
Clinuvel Pharmaceuticals Says It Has No Deposits at Silicon Valley Bank	13/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Other languages

Filters